Fig. 2From: Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective studyOverall survival (OS), progression-free survival (PFS) and intrahepatic PFS (IHPFS) in different groups. A The OS in the total cohort. B The PFS in the total cohort. C The IHPFS in the total cohortBack to article page